Cas:95348-44-0 2,2,3,3,4,4,5,5,6,6,6-undecadeuteriohexanoic acid manufacturer & supplier

We serve Chemical Name:2,2,3,3,4,4,5,5,6,6,6-undecadeuteriohexanoic acid CAS:95348-44-0 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

2,2,3,3,4,4,5,5,6,6,6-undecadeuteriohexanoic acid

Chemical Name:2,2,3,3,4,4,5,5,6,6,6-undecadeuteriohexanoic acid
CAS.NO:95348-44-0
Synonyms:Caproic acid-d11,OH;MFCD00144449;6,6,6,5,5,4,4,3,3,2,2-d11-hexanoic acid;hexanoic acid-d11;Hexanoic-d11 acid
Molecular Formula:C6HD11O2
Molecular Weight:127.22600
HS Code:

Physical and Chemical Properties:
Melting point:-3ºC(lit.)
Boiling point:202-203ºC(lit.)
Density:1.015 g/mL at 25ºC
Index of Refraction:n20/D 1.412(lit.)
PSA:37.30000
Exact Mass:127.15300
LogP:1.65130

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:UN 2829 8/PG 3
Packing Group:


Contact us for information like Caproic acid-d11,OH chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Hexanoic-d11 acid physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,hexanoic acid-d11 Use and application,Caproic acid-d11,OH technical grade,usp/ep/jp grade.


Related News: High viral load in the respiratory tract correlates with severe illness and mortality in patients with COVID-19,” said Zhiqiang An, PhD, director of UTHealth Texas Therapeutics Institute, professor and Robert A. Welch Distinguished University Chair in Chemistry at McGovern Medical School at UTHealth, and faculty member at MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences and one of the corresponding authors on the study.
“Respiratory mucosal antibodies are key to clearing SARS-CoV-2 infection and reducing viral transmission and IgM antibodies are nature’s first line of defense against pathogens such as viruses. N-(4-(4-chlorophenoxy)phenyl)-2-(diethylamino)acetamide oxalate manufacturers “We welcome a formal review into the interactions between the FDA and Biogen on the path to the approval of aducanumab,” Sandrock said. “A better understanding of the facts is good for everyone involved to assure confidence in both the therapy and the process by which it was approved as we prioritize the issues that affect patients.” piperidin-4-yl acetate,2,2,2-trifluoroacetic acid suppliers Patients having Zynteglo treatment for beta thalassaemia also need conditioning treatment to clear out their bone marrow cells before receiving Zynteglo. Healthcare professionals should therefore explicitly inform patients receiving Zynteglo of the increased risk of blood cancers from medicines used in conditioning treatments. Benzene, 2-chloro-4-isocyanato-1-[(2,2,2-trifluoroethyl)thio]- vendor & factory.